Evidence map›Paper›PMID 36428982›Full record

ArticleCells2022

Breast Cancer MCF-7 Cells Acquire Heterogeneity during Successive Co-Culture with Hematopoietic and Bone Marrow-Derived Mesenchymal Stem/Stromal Cells.

Ruoxiang Wang, Xudong Wang, Liyuan Yin, Lijuan Yin, Gina Chia-Yi Chu, Peizhen Hu, Yan Ou, Yi Zhang, Michael S Lewis, Stephen J Pandol

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ruoxiang WangDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0003-2614-8292
Xudong WangDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Liyuan YinDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Lijuan YinDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Gina Chia-Yi ChuDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Peizhen HuDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Yan OuDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Yi ZhangDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Michael S LewisDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0002-1892-4127
Stephen J PandolDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0003-0818-6017
Cedars-Sinai Medical Center · US

Funding

ROS Targeted Therapy for Lethal Prostate CancerR21CA256419 · NCI · CEDARS-SINAI MEDICAL CENTER · PI WANG, RUOXIANG, ZHANG, YI · 2021 to 2022
$425k
NCI NIH HHS R21 CA256419
6 · The paper itself

Abstract

During disease progression and bone metastasis, breast tumor cells interact with various types of bystander cells residing in the tumor microenvironment. Such interactions prompt tumor cell heterogeneity. We used successive co-culture as an experimental model to examine cancer-bystander cell interaction. RMCF7-2, a clone of the human breast cancer MCF-7 cells tagged with a red fluorescent protein, was tracked for morphologic, behavioral, and gene expression changes. Co-cultured with various types of hematopoietic cells, RMCF7-2 adopted stable changes to a rounded shape in suspension growth of red fluorescent cells, from which derivative clones displayed marked expressional changes of marker proteins, including reduced E-cadherin and estrogen receptor α, and loss of progesterone receptor. In a successive co-culture with bone marrow-derived mesenchymal stem/stromal cells, the red fluorescent clones in suspension growth changed once more, adopting an attachment growth, but in diversified shapes. Red fluorescent clones recovered from the second-round co-culture were heterogeneous in morphology, but retained the altered marker protein expression while displaying increased proliferation, migration, and xenograft tumor formation. Interaction with bystander cells caused permanent morphologic, growth behavioral, and gene expressional changes under successive co-culture, which is a powerful model for studying cancer cell heterogeneity during breast cancer progression and metastasis.

Indexed as

Breast NeoplasmsMesenchymal Stem CellsBone MarrowCoculture TechniquesFemaleHumansMCF-7 CellsTumor Microenvironmentbone marrow-derived mesenchymal stem/stromal cellsbreast cancerbystander cellscell–cell interactionco-culturegene expressionhematopoietic cellsheterogeneitymetastasis

Identifiers

PMID36428982
PMCPMC9688235
OpenAlexW4308870737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.